← Leaderboards
Vittorio Porciatti
University Of Miami School Of Medicine
$11,502,425
Attributed
$13,235,833
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$22,052,638 · 12
By mechanism
P30$11,798,864 · 8
R01$6,340,404 · 2
R24$3,466,817 · 1
R03$446,553 · 1
Top collaborators
- Byron L Lam4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Frank J Penedo$18,909,850
- Byron L Lam$1,733,412
- Sara J. Czaja$28,092,005
- Sanjoy K Bhattacharya$6,832,003
- Richard K Lee$1,150,182
Others in their field
Top investigators on “Vision Research”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$212,686,271
Research focus
Vision ResearchImageFundingResearch PersonnelBiometryServicesLaboratoriesGlaucomaExperimental ModelsBiologicalProgramsUnited States National Institutes Of HealthBlindnessBiophysicsApplications GrantsVisionVisual System StructurePreventOphthalmologyEnvironmentAxonUniversitiesEquipmentInstitutes
Grant awards (69)
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1
R24 · FY2023 · EY · contact PI
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1,061,273
R24 · FY2022 · EY · contact PI
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$1,509,194
R24 · FY2021 · EY · contact PI
Miami Center for Vision Research$428,006
P30 · FY2021 · EY · contact PI
Administrative Core$41,091
P30 · FY2021 · EY · contact PI
Mito-Targeted AAV to treat Leber Hereditary Optic Neuropathy caused by ND4 mutations$896,349
R24 · FY2020 · EY · contact PI
Miami Center for Vision Research$573,183
P30 · FY2019 · EY · contact PI
Administrative Core$38,608
P30 · FY2019 · EY · contact PI
Miami Center for Vision Research$580,472
P30 · FY2018 · EY · contact PI
Shared Equipment & Facilities Module$209,076
P30 · FY2018 · EY · contact PI
Biological Imaging Module$146,878
P30 · FY2018 · EY · contact PI
Experimental Models Module$121,311
P30 · FY2018 · EY · contact PI
Biostatics Module$70,088
P30 · FY2018 · EY · contact PI
Administration$33,119
P30 · FY2018 · EY · contact PI
Miami Center for Vision Research$580,472
P30 · FY2017 · EY · contact PI
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma$345,375
R01 · FY2017 · EY · contact PI
Shared Equipment & Facilities Module$209,076
P30 · FY2017 · EY · contact PI
Biological Imaging Module$146,878
P30 · FY2017 · EY · contact PI
Experimental Models Module$121,311
P30 · FY2017 · EY · contact PI
Biostatics Module$70,088
P30 · FY2017 · EY · contact PI
Administration$33,119
P30 · FY2017 · EY · contact PI
Miami Center for Vision Research$580,472
P30 · FY2016 · EY · contact PI
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma$345,375
R01 · FY2016 · EY · contact PI
Shared Equipment & Facilities Module$209,076
P30 · FY2016 · EY · contact PI
Biological Imaging Module$146,878
P30 · FY2016 · EY · contact PI
Experimental Models Module$121,311
P30 · FY2016 · EY · contact PI
Biostatics Module$70,088
P30 · FY2016 · EY · contact PI
Administration$33,119
P30 · FY2016 · EY · contact PI
Miami Center for Vision Research$580,472
P30 · FY2015 · EY · contact PI
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma$338,467
R01 · FY2015 · EY · contact PI
Retinal Ganglion Cell Plasticity in Glaucoma$335,962
R01 · FY2015 · EY · contact PI
Shared Equipment & Facilities Module$209,076
P30 · FY2015 · EY · contact PI
Biological Imaging Module$146,878
P30 · FY2015 · EY · contact PI
Experimental Models Module$121,311
P30 · FY2015 · EY · contact PI
Biostatics Module$70,088
P30 · FY2015 · EY · contact PI
Administration$33,119
P30 · FY2015 · EY · contact PI
Miami Center for Vision Research$580,472
P30 · FY2014 · EY · contact PI
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma$345,375
R01 · FY2014 · EY · contact PI
Retinal Ganglion Cell Plasticity in Glaucoma$335,962
R01 · FY2014 · EY · contact PI
Shared Equipment & Facilities Module$209,076
P30 · FY2014 · EY · contact PI
Miami Center for Vision Research$161,496
P30 · FY2014 · EY · contact PI
Biological Imaging Module$146,878
P30 · FY2014 · EY · contact PI
Experimental Models Module$121,311
P30 · FY2014 · EY · contact PI
Bilostatics Module$70,088
P30 · FY2014 · EY · contact PI
Administration$33,119
P30 · FY2014 · EY · contact PI
Miami Center for Vision Research$546,880
P30 · FY2013 · EY · contact PI
Retinal Ganglion Cell Plasticity in Glaucoma$323,412
R01 · FY2013 · EY · contact PI
Miami Center for Vision Research$629,249
P30 · FY2012 · EY · contact PI
Miami Center for Vision Research$497,662
P30 · FY2012 · EY · contact PI
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA$363,528
R01 · FY2012 · EY · contact PI
Retinal Ganglion Cell Plasticity in Glaucoma$338,526
R01 · FY2012 · EY · contact PI
Miami Center for Vision Research$629,303
P30 · FY2011 · EY · contact PI
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA$363,528
R01 · FY2011 · EY · contact PI
Miami Center for Vision Research$610,973
P30 · FY2010 · EY · contact PI
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA$378,675
R01 · FY2010 · EY · contact PI
RETINAL GANGLION CELL PLASTICITY IN GLAUCOMA$373,785
R01 · FY2010 · EY · contact PI
Miami Center for Vision Research$593,179
P30 · FY2009 · EY · contact PI
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA$382,500
R01 · FY2009 · EY · contact PI
RETINAL GANGLION CELL PLASTICITY IN GLAUCOMA$373,317
R01 · FY2009 · EY · contact PI
Miami Center for Vision Research$630,272
P30 · FY2008 · EY · contact PI
REVERSIBLE GANGLION CELL DYSFUNCTION IN GLAUCOMA$382,500
R01 · FY2008 · EY · contact PI
Miami Center for Vision Research$614,242
P30 · FY2007 · EY · contact PI
Reversible Ganglion Cell Dysfunction in Glaucoma$294,224
R01 · FY2007 · EY · contact PI
LIFE AND DEATH OF RETINAL GANGLION CELLS$147,113
R03 · FY2007 · EY · contact PI
Reversible Ganglion Cell Dysfunction in Glaucoma$360,014
R01 · FY2006 · EY · contact PI
LIFE AND DEATH OF RETINAL GANGLION CELLS$147,940
R03 · FY2006 · EY · contact PI
Reversible Ganglion Cell Dysfunction in Glaucoma$328,000
R01 · FY2005 · EY
LIFE AND DEATH OF RETINAL GANGLION CELLS$151,500
R03 · FY2005 · EY
Reversible Ganglion Cell Dysfunction in Glaucoma$31,879
R01 · FY2005 · EY